Basaglar: A Hypersensitivity Reaction
Article Figures & Tables
Tables
- TABLE 1.
Proportion of Patients With Detected Antibodies in the ELEMENT 2 Trial
Population Visit Basaglar Patients With Detected Antibodies (n [%]) Lantus Patients With Detected Antibodies (n [%]) Full analysis set Baseline 20 (5.5) 13 (3.6) Week 24 overall 56 (15.3) 40 (11.0) Week 24 LOCF 30 (8.2) 22(6.0) Previous Lantus patients Baseline 10 (6.6) 6 (4.4) Week 24 overall 29 (19.2) 11 (7.9) Week 24 LOCF 13 (8.6) 5 (3.6) Previously insulin-naive patients Baseline 10 (4.7) 7 (3.1) Week 24 overall 27 (12.6) 29 (12.8) Week 24 LOCF 17 (7.9) 17 (7.5)